U.S. court invalidates patent on J & J cancer drug Zytiga

NEW YORK (Reuters) - A U.S. administrative court on Wednesday invalidated a Johnson& Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news